Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
Bergamini M, Dalla Volta A, Palumbo C, Zamboni S, Triggiani L, Zamparini M, Laganà M, Rinaudo L, Di Meo N, Caramella I, Bresciani R, Valcamonico F, Borghetti P, Guerini A, Farina D, Antonelli A, Simeone C, Mazziotti G, Berruti A. Bergamini M, et al. Among authors: dalla volta a. Elife. 2024 Apr 24;13:e92655. doi: 10.7554/eLife.92655. Elife. 2024. PMID: 38656229 Free PMC article. Clinical Trial.
Resistance to Hormonal Therapy in Prostate Cancer.
Berruti A, Dalla Volta A. Berruti A, et al. Among authors: dalla volta a. Handb Exp Pharmacol. 2018;249:181-194. doi: 10.1007/164_2017_21. Handb Exp Pharmacol. 2018. PMID: 28353036
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study.
Palumbo C, Antonelli A, Triggiani L, Dalla Volta A, Maffezzoni F, Zamboni S, Borghetti P, Rinaudo L, Valcamonico F, Maroldi R, Magrini SM, Simeone C, Berruti A; Collaborators. Palumbo C, et al. Among authors: dalla volta a. Prostate Cancer Prostatic Dis. 2021 Sep;24(3):852-859. doi: 10.1038/s41391-021-00345-0. Epub 2021 Mar 15. Prostate Cancer Prostatic Dis. 2021. PMID: 33723362 Free PMC article. Clinical Trial.
Effect of Degarelix Administration on Bone Health in Prostate Cancer Patients Without Bone Metastases. The Blade Study.
Palumbo C, Dalla Volta A, Zamboni S, Mazziotti G, Zamparini M, Triggiani L, Borghetti P, Maffezzoni F, Bresciani R, Rinaudo L, Valcamonico F, Farina D, Magrini SM, Antonelli A, Simeone C, Berruti A. Palumbo C, et al. Among authors: dalla volta a. J Clin Endocrinol Metab. 2022 Nov 25;107(12):3398-3407. doi: 10.1210/clinem/dgac489. J Clin Endocrinol Metab. 2022. PMID: 35971857
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study.
Dalla Volta A, Palumbo C, Zamboni S, Mazziotti G, Triggiani L, Zamparini M, Maffezzoni F, Rinaudo L, Bergamini M, Di Meo N, Caramella I, Valcamonico F, Borghetti P, Guerini A, Farina D, Antonelli A, Simeone C, Berruti A. Dalla Volta A, et al. J Endocrinol Invest. 2024 Feb;47(2):335-343. doi: 10.1007/s40618-023-02150-z. Epub 2023 Jul 17. J Endocrinol Invest. 2024. PMID: 37458931 Free PMC article.
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group.
Bardoscia L, Triggiani L, Sandri M, Francavilla S, Borghetti P, Dalla Volta A, Veccia A, Tomasini D, Buglione M, Valcamonico F, Simeone C, Berruti A, Magrini SM, Antonelli A. Bardoscia L, et al. Among authors: dalla volta a. World J Urol. 2021 Apr;39(4):1161-1170. doi: 10.1007/s00345-020-03315-8. Epub 2020 Jun 26. World J Urol. 2021. PMID: 32591899
68 results